Trials / Completed
CompletedNCT00721656
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
A Randomized, Double Blind, Placebo Controlled, Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | KLS-0611 |
Timeline
- First posted
- 2008-07-24
- Last updated
- 2009-03-18
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00721656. Inclusion in this directory is not an endorsement.